Cambridge Investment Research Advisors’s Maxim Integrated Products MXIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,653
| Closed | -$596K | – | 3260 |
|
|
2021
Q2 | $596K | Sell |
5,653
-5,399
| -49% | -$528K | ﹤0.01% | 1918 |
|
|
2021
Q1 | $1.01M | Sell |
11,052
-304
| -3% | -$27.9K | 0.01% | 1428 |
|
|
2020
Q4 | $1.01M | Buy |
11,356
+673
| +6% | +$53.1K | 0.01% | 1295 |
|
|
2020
Q3 | $722K | Buy |
10,683
+4,081
| +62% | +$276K | ﹤0.01% | 1378 |
|
|
2020
Q2 | $400K | Buy |
6,602
+263
| +4% | +$14.6K | ﹤0.01% | 1686 |
|
|
2020
Q1 | $308K | Buy |
6,339
+834
| +15% | +$47.8K | ﹤0.01% | 1667 |
|
|
2019
Q4 | $339K | Sell |
5,505
-10,573
| -66% | -$616K | ﹤0.01% | 1836 |
|
|
2019
Q3 | $931K | Buy |
16,078
+514
| +3% | +$29.8K | 0.01% | 1112 |
|
|
2019
Q2 | $931K | Sell |
15,564
-36
| -0.2% | -$2.05K | 0.01% | 1051 |
|
|
2019
Q1 | $829K | Sell |
15,600
-2,732
| -15% | -$147K | 0.01% | 1139 |
|
|
2018
Q4 | $932K | Buy |
18,332
+134
| +0.7% | +$7K | 0.01% | 966 |
|
|
2018
Q3 | $1.03M | Buy |
18,198
+510
| +3% | +$30.8K | 0.01% | 1013 |
|
|
2018
Q2 | $1.04M | Sell |
17,688
-1,165
| -6% | -$67.8K | 0.01% | 950 |
|
|
2018
Q1 | $1.14M | Sell |
18,853
-1,321
| -7% | -$78.3K | 0.01% | 874 |
|
|
2017
Q4 | $1.05M | Sell |
20,174
-434
| -2% | -$22.6K | 0.01% | 877 |
|
|
2017
Q3 | $983K | Buy |
20,608
+2,697
| +15% | +$124K | 0.01% | 853 |
|
|
2017
Q2 | $804K | Sell |
17,911
-1,166
| -6% | -$53.6K | 0.01% | 919 |
|
|
2017
Q1 | $858K | Buy |
19,077
+1,328
| +7% | +$58.2K | 0.01% | 802 |
|
|
2016
Q4 | $685K | Buy |
17,749
+580
| +3% | +$22.8K | 0.01% | 860 |
|
|
2016
Q3 | $686K | Buy |
17,169
+517
| +3% | +$20.4K | 0.01% | 863 |
|
|
2016
Q2 | $594K | Sell |
16,652
-34
| -0.2% | -$1.25K | 0.01% | 859 |
|
|
2016
Q1 | $614K | Buy |
16,686
+113
| +0.7% | +$3.79K | 0.01% | 787 |
|
|
2015
Q4 | $630K | Sell |
16,573
-787
| -5% | -$30.1K | 0.01% | 754 |
|
|
2015
Q3 | $580K | Sell |
17,360
-396
| -2% | -$13.1K | 0.02% | 691 |
|
|
2015
Q2 | $614K | Buy |
17,756
+2,602
| +17% | +$89K | 0.02% | 710 |
|
|
2015
Q1 | $528K | Sell |
15,154
-319
| -2% | -$10.9K | 0.02% | 765 |
|
|
2014
Q4 | $493K | Buy |
15,473
+497
| +3% | +$14.6K | 0.02% | 789 |
|
|
2014
Q3 | $453K | Buy |
14,976
+491
| +3% | +$15.4K | 0.01% | 879 |
|
|
2014
Q2 | $490K | Sell |
14,485
-1,867
| -11% | -$62.2K | 0.02% | 764 |
|
|
2014
Q1 | $542K | Buy |
16,352
+2,578
| +19% | +$79.2K | 0.02% | 682 |
|
|
2013
Q4 | $384K | Buy |
13,774
+3,493
| +34% | +$101K | 0.02% | 769 |
|
|
2013
Q3 | $307K | Buy |
10,281
+2,243
| +28% | +$63.8K | 0.01% | 828 |
|
|
2013
Q2 | $223K | Buy |
+8,038
| New | +$244K | 0.01% | 892 |
|
Other funds holding MXIM
Cambridge Investment Research Advisors's MXIM Position: Q3 2021 in Review
Cambridge Investment Research Advisors sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 5,653 shares — an estimated $596K sold.
Cambridge Investment Research Advisors first reported a position in MXIM in Q2 2013 and held it in 33 quarters. The position peaked at $1.14M in Q1 2018. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.
- Cambridge Investment Research Advisors reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 5,653 Maxim Integrated Products shares in Q3 2021, an estimated $596K.
- Cambridge Investment Research Advisors first reported a position in Maxim Integrated Products in Q2 2013 and held it in 33 quarters.
- Cambridge Investment Research Advisors's Maxim Integrated Products position peaked at $1.14M in Q1 2018.
- 3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.